Top 10 significant functional annotations of down-regulated DEGs. by Meitner Cadena (22216261)

“…Functional annotations are ordered by decreasing significance, with color indicating significance level based on the legend’s color scale, the ratio of genes on the horizontal axis, and DEG count represented by circle size.…”

Counts and age-standardized rate of carcinoid tumor incidence per 100,000 and average annual percent change from 2000 to 2019 in the United States, by age, sex, and race. by Armin Aslani (13009188)

Subjects:

Clinical characteristics of patients and controls. by Duangnapa Roongpiboonsopit (12829198)

Subjects:

Age-adjusted incidence rate of gastric cancer over 2000–2019 and in 2020 in the United States, by histologic type. by Armin Aslani (13009188)

Subjects:

Counts and age-standardized rate of gastric cancer incidence per 100,000 and average annual percent change from 2000 to 2019 in the United States, by age, sex, and race. by Armin Aslani (13009188)

Subjects:

Counts and age-standardized rate of gastric adenocarcinoma incidence per 100,000 and average annual percent change from 2000 to 2019 in the United States, by age, sex, and race. by Armin Aslani (13009188)

Subjects:

Alpha-diversity analysis at genus level including operational taxonomic unit (OTUs), Chao richness and Shannon diversity indices. by Duangnapa Roongpiboonsopit (12829198)

Subjects:

Percent change in age-standardized and delay-adjusted incidence rates of gastric cancer from 2019 to 2020, by age, race and sex in the United States, using the November 2022 data s... by Armin Aslani (13009188)

Subjects:

Counts and age-standardized rate of signet ring carcinoma incidence per 100,000 and average annual percent change from 2000 to 2019 in the United States, by age, sex, and race. by Armin Aslani (13009188)

Subjects:

Counts and age-standardized rate of gastrointestinal stromal tumor incidence per 100,000 and average annual percent change from 2000 to 2019 in the United States, by age, sex, and... by Armin Aslani (13009188)

Subjects:

Average percent relative abundance of top 10 most abundance species of healthy control and stroke patient groups. by Duangnapa Roongpiboonsopit (12829198)

Subjects:

Rarefaction curves of quality reads per sample at (A) phylum and (B) genus level operational taxonomic units (OTUs), in patient and control samples. by Duangnapa Roongpiboonsopit (12829198)

Subjects:

(A) Beta-diversity non-metric multidimensional scaling (NMDS) analysis at genus level, and (B) LEfSe for bacterial species biomarkers representing control vs. stroke groups. by Duangnapa Roongpiboonsopit (12829198)

Subjects:

Microbial metabolic potentials categorized according to KEGG (A) level 1 and (B) level 2, representing control vs. stroke groups. by Duangnapa Roongpiboonsopit (12829198)

Subjects:

Sociodemographic characteristics of participants at baseline, overall and by age group. by Chelsea S. Lutz (16001569)

Subjects:

Clinical outcomes and COVID-19 treatment during acute illness, by hospitalization status and age group. by Chelsea S. Lutz (16001569)

Subjects:

Symptoms self-reported and/or documented in the electronic health record during the acute COVID-19 illness, by hospitalization status and age group. by Chelsea S. Lutz (16001569)

Subjects:

Sociodemographic and clinical characteristics associated with PCC at three months post-acute illness among adults enrolled during Omicron predominance. by Chelsea S. Lutz (16001569)

Subjects:

Microbiota compositions in percent relative abundance between healthy control and stroke patient individuals (the average microbiota between groups were displayed on the rightmost... by Duangnapa Roongpiboonsopit (12829198)

Subjects:

Manifestations of Post-COVID-19 Conditions (PCC) three months post-acute illness, among those with PCC, by age group^a. by Chelsea S. Lutz (16001569)

Subjects: